Certara Products - Simcyp Archives

Press Coverage

Pregnant women, long excluded from drug trials, are back in the spotlight

Certara’s Karen Yeo discusses FDA’s draft guidance to include pregnant and breastfeeding women in clinical…

Certara2025 年 10 月 17 日

Live Events

PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software

– Scarman, Coventry, UK

Certara2025 年 10 月 14 日

Blog

肿瘤领域模型引导的药物开发（MIDD）精要

Model-informed drug development in oncology is critical to developing safer and more effective cancer drugs.…

Certara2025 年 10 月 6 日

Announcement

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…

Certara2025 年 9 月 22 日

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – 2025 年 9 月 17 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…

Certara2025 年 9 月 17 日

Conference

BioTechX US 2025

– – Booth

Simona Colucci2025 年 8 月 15 日

Press Coverage

药代动力学/药效学研究的建模方法

Explore insights from Certara experts on how PK/PD modeling streamlines biologic drug development.

Certara2025 年 8 月 5 日

Blog

开辟新领域：Simcyp® Simulator 获 EMA 认证开启 PBPK 建模新时代

The Simcyp Simulator receives EMA qualification—the first and only PBPK platform formally qualified for any…

Certara2025 年 8 月 5 日

On-Demand Webinar

监管前沿的机制模型：来自欧洲药品管理局（EMA）对 Simcyp® Simulator 的认证洞见

The European Medicines Agency (EMA) formally qualified Certara’s Simcyp® Simulator, marking the first and only…

Certara2025 年 8 月 4 日

Press Release

Certara Simcyp® Simulator 成为首个且唯一获得欧洲药品管理局（EMA）认证的 PBPK 建模软件平台

Certara announces that EMA has formally qualified the Simcyp® Simulator for use in regulatory submissions…

Certara2025 年 8 月 4 日

Certara Products – Simcyp